PHARMAPLUS ROCOURT
ActiveSummary
The computed 12-month bankruptcy probability of PHARMAPLUS ROCOURT is 2.8% (moderate). The 2025 annual accounts show negative equity (-€28,859) and a net result of €32,216. Equity is growing by about 33% per year across the filed financial years. Its solvency ranks better than 10% of 4,937 sector peers (NACE 47, financial year 2025). The company has been active since 1979 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Name clauseThe name the company operates under according to its articles.
- PHARMAPLUS ROCOURT
Read from the deeds: 1 provision, deed of 08-09-2026